Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Sep;79(9):1129-1131.
doi: 10.1136/annrheumdis-2020-218694. Epub 2020 Aug 4.

To immunosuppress: whom, when and how? That is the question with COVID-19

Affiliations
Editorial

To immunosuppress: whom, when and how? That is the question with COVID-19

Kevin L Winthrop et al. Ann Rheum Dis. 2020 Sep.
No abstract available

Keywords: arthritis; biological therapy; glucocorticoids; rheumatoid.

PubMed Disclaimer

Conflict of interest statement

Competing interests: KLW reports personal fees from Pfizer, AbbVie, Union Chimique Belge (UCB), Eli Lilly & Company, Galapagos, GlaxoSmithKline (GSK), Roche, and Gilead and reports research grants from BMS, Pfizer, outside the submitted work.

Comment on

References

    1. Ramiro S, Mostard RLM, Magro-Checa C, et al. . Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the chiC study. Ann Rheum Dis 2020;79:1142–50. 10.1136/annrheumdis-2020-218479 - DOI - PMC - PubMed
    1. Brenner EJ, Ungaro RC, Gearry RB, et al. . Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology 2020. 10.1053/j.gastro.2020.05.032 - DOI - PMC - PubMed
    1. George MD, Baker JF, Winthrop KL, et al. . Immunosuppression and the risk of readmission and mortality in patients with rheumatoid arthritis undergoing hip fracture, abdominopelvic and cardiac surgery. Ann Rheum Dis 2020;79:573–80. 10.1136/annrheumdis-2019-216802 - DOI - PMC - PubMed
    1. Faleck DM, Shmidt E, Huang R, et al. . Effect of concomitant therapy with steroids and tumor necrosis factor antagonists for induction of remission in patients with Crohn's disease: a systematic review and pooled meta-analysis. Clin Gastroenterol Hepatol 2020. doi:10.1016/j.cgh.2020.06.036. [Epub ahead of print: 19 Jun 2020]. - DOI - PMC - PubMed
    1. Rosenbaum JT, Hamilton H, Choi D, et al. . . biologics, spondylitis and COVID-19. Ann Rheum Dis 2020. - PubMed

Supplementary concepts